“Cancer research” is a broad term that encompasses everything from basic bench science, to translational research on patient-derived tumor specimens, to clinical trials, to studies on patient centered outcomes. While it is obvious to all of us in the lung cancer community that research is critical to improving patient outcomes, lung cancer remains underfunded compared to other common cancers. Several different mechanisms exist to fund cancer research, including private philanthropy, Big Pharma, not-for-profit cancer research and advocacy groups, and government organizations including the DOD and NIH/NCI among others. Given funding imbalances, it… Read More
- #LCSM Chat Topic 12/03/2020: 2020–Wild Year for #LungCancer
- #LCSM Chat Topic 11/05/2020: Celebrating Safely During #COVID-19 Pandemic
- #LCSM Chat Topic 10/01/2020: Crazy year, crazy progress–#lungcancer at #ESMO20
- #LCSM Chat Topic 9/3/2020: Is #Cancer Advocacy for Everyone?
- #LCSM Chat Topic 8/6/2020: Update on #COVID19 and #LungCancer
#LCAM14 ALK biomarker cancer treatment plans clinical research clinical trials COVID-19; antigen test Drugs EGFR epatients immunotherapy LDCT lung cancer lung cancer awareness month lung cancer risk factors lung cancer screening Medicare coverage of LDCT over-treatment patient advocates PCORI Screening self-advocacy shared decision making trials World Cancer Day